Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Immunopathologia Persa is Scopus-indexed (Q3, CiteScore 1.5), WoS ESCI. Published by Nickan Research Institute.
Checked against the index lists dated .
ISSN 2423-8015Verify ISSN ↗
Publisher: Nickan Research Institute
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Hematology | 106 / 151 | 30th | Q3 |
| Immunology and Microbiology (miscellaneous) | 31 / 43 | 29th | Q3 |
| Endocrinology, Diabetes and Metabolism | 191 / 250 | 23rd | Q4 |
| Immunology | 206 / 243 | 15th | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q3, CiteScore 1.5.
Immunopathologia Persa is Q3 in Hematology (rank 106 of 151), Q3 in Immunology and Microbiology (miscellaneous) (rank 31 of 43) and Q4 in Endocrinology, Diabetes and Metabolism (rank 191 of 250), by CiteScore 2025. It is ranked in 4 subject areas in all.
Immunopathologia Persa is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.5, which places it in quartile Q3 at the 30th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.232, quartile Q4, with an H-index of 10.
Immunopathologia Persa is published by Nickan Research Institute. Its ISSN is 2423-8015.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Immunopathologia Persa has an h-index of 11 and a 2-year mean of 0.96 citations per paper (OpenAlex). Its Scopus CiteScore is 1.5, quartile Q3. On 2-year citations it ranks #94 of 148 Scopus journals in Hematology.
Immunopathologia Persa published 53 papers in 2025; its busiest recent year was 2022 with 74. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2023–2026), authors are most often from Iran (62.8%), Iraq (20%) and Egypt (4.8%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.